Centiva Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,858
| Closed | -$284K | – | 1356 |
|
|
2024
Q4 | $284K | Sell |
1,858
-4,487
| -71% | -$686K | 0.01% | 877 |
|
|
2024
Q3 | $1.23M | Buy |
6,345
+4,108
| +184% | +$796K | 0.02% | 402 |
|
|
2024
Q2 | $519K | Buy |
+2,237
| New | +$519K | 0.01% | 763 |
|
|
2023
Q4 | – | Sell |
-2,013
| Closed | -$517K | – | 1280 |
|
|
2023
Q3 | $517K | Buy |
+2,013
| New | +$517K | 0.01% | 577 |
|
|
2023
Q1 | – | Sell |
-6,038
| Closed | -$1.67M | – | 1109 |
|
|
2022
Q4 | $1.67M | Buy |
6,038
+3,584
| +146% | +$992K | 0.05% | 195 |
|
|
2022
Q3 | $655K | Sell |
2,454
-17,711
| -88% | -$4.73M | 0.01% | 448 |
|
|
2022
Q2 | $4.11M | Sell |
20,165
-4,804
| -19% | -$980K | 0.1% | 102 |
|
|
2022
Q1 | $5.26M | Buy |
24,969
+15,466
| +163% | +$3.26M | 0.1% | 64 |
|
|
2021
Q4 | $2.28M | Buy |
9,503
+4,665
| +96% | +$1.12M | 0.05% | 147 |
|
|
2021
Q3 | $1.37M | Buy |
4,838
+2,966
| +158% | +$839K | 0.09% | 179 |
|
|
2021
Q2 | $648K | Buy |
+1,872
| New | +$648K | 0.02% | 452 |
|
|
2021
Q1 | – | Sell |
-4,610
| Closed | -$1.13M | – | 928 |
|
|
2020
Q4 | $1.13M | Sell |
4,610
-6,070
| -57% | -$1.49M | 0.04% | 130 |
|
|
2020
Q3 | $3.03M | Buy |
10,680
+2,905
| +37% | +$824K | 0.2% | 42 |
|
|
2020
Q2 | $2.08M | Buy |
7,775
+5,388
| +226% | +$1.44M | 0.13% | 46 |
|
|
2020
Q1 | $755K | Sell |
2,387
-7,946
| -77% | -$2.51M | 0.03% | 138 |
|
|
2019
Q4 | $3.07M | Sell |
10,333
-4,455
| -30% | -$1.32M | 0.15% | 21 |
|
|
2019
Q3 | $3.44M | Buy |
14,788
+14,755
| +44,712% | +$3.44M | 0.21% | 21 |
|
|
2019
Q2 | $8K | Sell |
33
-1,884
| -98% | -$457K | ﹤0.01% | 168 |
|
|
2019
Q1 | $453K | Buy |
+1,917
| New | +$453K | 0.03% | 67 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 107 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 57 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 35 |
|